GMP Securities kicks off 2019 Cannabis Conference looking at the industry post-legalization
Tuesday, 16 April 2019 The GMP Cannabis Conference 2019 kicked off Tuesday at the Ritz Carlton Hotel in Toronto. More than 700 cannabis industry executives gathered at the third annual event to discuss the evolution of the sector post-Canadian legalization, while looking to the future and the potential of the biggest market south of the border: the United States. There is continued interest in how Canadian cannabis companies will operate globally, according to Steve Ottaway, managing director, investment banking at GMP Securities. “If cannabis companies are looking at the US, they need to try to determine how they are going to participate in what is arguably the largest market in the world,” he said in a recent interview with Proactive. Demand for information on the sector continues to increase. GMP Securities is not confined to only underwrite Canadian companies, hence the variety of companies presenting, Ottaway said in his opening remarks at the conference. Leading cannabis companies Canopy Growth Corporation (NYSE:CGC) (TSE:WEED) and Aurora Cannabis Inc (NYSE:ACB) (TSE:ACB) will speak to investors about their business post-legalization, and where the business is headed in the future. Other cannabis companies such as The Green Organic Dutchman Holdings Inc (TSE:TGOD) (OTCMKTS:TGODF) , MediPharm Labs Corp (OTCMKTS:MEDIF), The Flowr Corporation and HEXO Corp (TSE:HEXO) (NYSEAMERICAN:HEXO) will talk about gaining market share and brand loyalty in what is estimated to be a nearly $10 billion Canadian industry. MedMen Enterprises Inc (CSE:MMEN) (OTCMKTS:MMNFF), Harvest Health and Recreation (OTCMKTS:HRVSF) (CSE:HARV), Green Thumb Industries Inc (CSE:MMEN) (OTCQX:MMNFF) and Curaleaf Holdings (CSE:CURA) (OTCBB:CURLF) will talk about their experience in the US market, and whether legalization will be good for business and growing their companies abroad. Contact Angela at email@example.com Follow her on Twitter @AHarmantas
Canadian cannabis giant Canopy Growth announced on Thursday a major deal to acquire Acreage Holdings, a U.S. medical cannabis company whose board includes former U.S. House Speaker John Boehner. The blockbuster deal will effectively cement the Canopy's presence in the burgeoning U.S. marijuana...
Tilray said first-quarter revenue rose 195% from a year earlier to $23 million, as sales in Canada surged following the country's decision to legalize cannabis for recreational use. The adjusted loss..
Let's dive into the markets, Real Money's Stock of the Day Macy's and the cannabis sector. What's Going on in the Markets? After all of the trade news we've gotten this week, and the market reaction,..
Medical cannabis could become an investment bubble in Israel, the country's market regulator warned, as cash floods into a rapidly-expanding industry where few companies yet make money. Rough cut (no..
Credit: Reuters - Business (Amazon FireT Duration: 00:59Published
Business Insider reports the US marijuana industry is worth billions of dollars, and is showing no signs of slowing down.
Ten US states have legalized recreational marijuana use, and 33 have legalized..